A role for CXCL12 (SDF-1α) in the pathogenesis of multiple sclerosis:: Regulation of CXCL12 expression in astrocytes by soluble myelin basic protein

被引:142
作者
Calderon, Tina M.
Eugenin, Eliseo A.
Lopez, Lillie
Kumar, Sridhar Sampath
Hesselgesser, Joseph
Raine, Cedric S.
Berman, Joan W.
机构
[1] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[2] Gilead Sci, Dept Immunol, Foster City, CA USA
关键词
CXCL12; multiple sclerosis; chemokines; MBP; signaling;
D O I
10.1016/j.jneuroim.2006.05.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pathogenic mechanisms that contribute to multiple sclerosis (MS) include leukocyte chemotaxis into the central nervous system (CNS) and the production of inflammatory mediators, resulting in oligodendrocyte damage, demyelination, and neuronal injury. Thus, factors that regulate leukocyte entry may contribute to early events in MS, as well as to later stages of lesion pathogenesis. CXCL12 (SDF-1 alpha), a chemokine essential in CNS development and a chemoattractant for resting and activated T cells, as well as monocytes, is constitutively expressed at low levels in the CNS and has been implicated in T cell and monocyte baseline trafficking. To determine whether CXCL12 is increased in MS, immunohistochemical analyses of lesions of chronic active and chronic silent MS were performed. CXCL12 protein was detected on endothelial cells (EC) in blood vessels within normal human brain sections and on a small number of astrocytes within the brain parenchyma. In active MS lesions, CXCL12 levels were high on astrocytes throughout lesion areas and on some monocytes/macrophages within vessels and perivascular cuffs, with lesser staining on EC. In silent MS lesions, CXCL12 staining was less than that observed in active MS lesions, and also was detected on EC and astrocytes, particularly hypertrophic astrocytes near the lesion edge. Experiments in vitro demonstrated that IL-1 beta and myelin basic protein (MBP) induced CXCL12 in astrocytes by signaling pathways involving ERK and PI3-K. Human umbilical vein-EC did not produce CXCL12 after treatment with MBP or IL-1 beta. However, these EC cultures expressed CXCR4, the receptor for CXCL12, suggesting that this chemokine may activate EC to produce other mediators involved in MS. In agreement, EC treatment with CXCL12 was found to upregulate CCL2 (MCP-1) and CXCL8 (IL-8) by PI3-K and p38-dependent mechanisms. Our findings suggest that increased CXCL12 may initiate and augment the inflammatory response during MS. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:27 / 39
页数:13
相关论文
共 64 条
[51]   Glucose regulates monocyte adhesion through endothelial production of interleukin-8 [J].
Srinivasan, S ;
Yeh, M ;
Danziger, EC ;
Hatley, ME ;
Riggan, AE ;
Leitinger, N ;
Berliner, JA ;
Hedrick, CC .
CIRCULATION RESEARCH, 2003, 92 (04) :371-377
[52]   Multiple sclerosis: a two-stage disease [J].
Steinman, L .
NATURE IMMUNOLOGY, 2001, 2 (09) :762-764
[53]  
Stumm RK, 2002, J NEUROSCI, V22, P5865
[54]  
Tanabe S, 1997, J IMMUNOL, V159, P905
[55]   SIGNAL SEQUENCE TRAP - A CLONING STRATEGY FOR SECRETED PROTEINS AND TYPE-I MEMBRANE-PROTEINS [J].
TASHIRO, K ;
TADA, H ;
HEILKER, R ;
SHIROZU, M ;
NAKANO, T ;
HONJO, T .
SCIENCE, 1993, 261 (5121) :600-603
[56]   Developmental pattern of expression of the alpha chemokine stromal cell-derived factor 1 in the rat central nervous system [J].
Tham, TN ;
Lazarini, F ;
Franceschini, IA ;
Lachapelle, F ;
Amara, A ;
Dubois-Dalcq, M .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2001, 13 (05) :845-856
[57]   Axonal transection in the lesions of multiple sclerosis [J].
Trapp, BD ;
Peterson, J ;
Ransohoff, RM ;
Rudick, R ;
Mörk, S ;
Bö, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05) :278-285
[58]  
UBUGO EE, 2006, TRENDS PHARMACOL SCI, V27, P48
[59]  
WEKERLE H, 1998, IMMUNOLOGY MULTIPLE
[60]   MYELIN ENCEPHALITOGENIC PROTEIN FRAGMENTS IN CEREBROSPINAL-FLUID OF PERSONS WITH MULTIPLE-SCLEROSIS [J].
WHITAKER, JN .
NEUROLOGY, 1977, 27 (10) :911-920